These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8831876)

  • 1. Atrial fibrillation and stroke prevention in the community.
    O'Connell JE; Gray CS
    Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional risk factors in atrial fibrillation patients not receiving warfarin.
    Wensley S; Keir S; Caine S; Mac Mahon M
    Age Ageing; 1999 Jul; 28(4):355-7. PubMed ID: 10459787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing stroke in patients with atrial fibrillation.
    Ezekowitz MD; Levine JA
    JAMA; 1999 May; 281(19):1830-5. PubMed ID: 10340371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of stroke.
    Martinez-Riera A; Santolaria-Fernandez F; Gonzalez-Reimers E
    N Engl J Med; 1996 Apr; 334(17):1138; author reply 1139. PubMed ID: 8598884
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
    Stratton JR
    West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577
    [No Abstract]   [Full Text] [Related]  

  • 13. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
    Hart RG; Benavente O; McBride R; Pearce LA
    Ann Intern Med; 1999 Oct; 131(7):492-501. PubMed ID: 10507957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
    Ghaswalla PK; Harpe SE; Slattum PW
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin, aspirin, and atrial fibrillation.
    Harv Heart Lett; 1998 Aug; 8(12):4-6. PubMed ID: 9713234
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
    Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
    Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
    Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.